Executive Directors

• Dr. Wang Hao - Executive Director, Chief Executive Officer and Chief Scientist

  Dr. Wang Hao (“Dr. Wang”) was appointed as an Executive Director and Chief Scientist of the Company in August 2018, and he was appointed as the Chief Executive Officer of the Company in October 2020, primarily responsible for overseeing the Group’s operation and management.

  Dr. Wang joined our Group and served as a Deputy General Manager of Taizhou Pharmaceutical since January 2017 and resigned in March 2017. Dr. Wang was appointed as a director of Taizhou Pharmaceutical in August 2018. Dr. Wang has over 21 years of experience in the medical and pharmaceutical technology industry.

  Dr. Wang was awarded twice with the National Award for Science and Technology Progress in December 2011 and December 2007, respectively, the Shanghai Oriental Scholar Professorship in June 2008, and the Shanghai Award for Science and Technology Progress in December 2003.
  
  

• Mr. Li Yunfeng - Executive Director, Chief Financial Officer and Joint Company Secretary

  Mr. Li Yunfeng (“Mr. Li”) was appointed as an Executive Director, Chief Financial Officer and Joint Company Secretary of our Company in August 2018, primarily responsible for overseeing the Group’s management of finance, investment and legal work. Mr. Li joined our Group and served as a Deputy General Manager of Taizhou Pharmaceutical since March 2016. Mr. Li has over 17 years of experience in the biotechnology industry.
  
  

• Dr. Li Jing - Executive Director and Vice President

  Dr. Li Jing (“Dr. Li”) was appointed as an Executive Director and  Vice President of our Company in August 2018. Dr. Li is primarily responsible for supervising clinical trials and registration affairs of our Group. Dr. Li joined our Group and served as a Deputy General Manager of Taizhou Pharmaceutical since February 2015. Dr. Li has more than 17 years of experience in the biotechnology industry.

  Dr. Li was accredited as a senior pharmaceutical engineer by Guangdong Medical and Pharmaceutical Advanced Professional Qualification Advisory Committee in February 2001. In May 2007, Dr. Li was appointed by Shanghai Municipal Science and Technology Commission as a technology foresight expert in key areas of science and technology development for the year of 2007 to 2008. Dr. Li received Shanghai Municipality's Excellent Discipline Leaders Program (Category B) Scholarship in November 2007. She was also appointed as a member of the Committee of Quality Expert of China Protein Drug Quality Alliance in March 2016, serving from March 2016 to March 2019. In August 2017, Dr. Li was appointed as a member of the Chinese Pharmacopoeia Commission.
  
  

• Mr. Tao Jing - Executive Director and  Vice President

  Mr. Tao Jing (“Mr. Tao”) joined Taizhou Pharmaceutical in February 2015 as its Deputy General Manager and was appointed as the Vice President of the Company and General Manager of Taizhou Pharmaceutical in August 2018 and an Executive Director of the Company in October 2020. He is primarily responsible for overseeing the Group’s production of drugs. Mr. Tao received a bachelor degree in Biochemistry from Anhui University in July 1994. He also obtained an advanced certificate in biochemistry from Shanghai Municipal Human Resources and Social Security Bureau in November 2013.

   

Non-executive Directors

• Mr. Guo Jianjun - Non-executive Director

  Mr. Guo Jianjun (“Mr. Guo”) was appointed as a Non-Executive Director in August, 2018. He is mainly responsible for participating in decision-making of important matters of our Group. Mr. Guo received education in Mining Machinery at Luoyang Mining Machinery Factory Workers College and obtained a tertiary degree in mining machine in June 1982.

• Mr. Jiao Shuge - Chairman and a non-executive Director

  Mr. Jiao Shuge (“Mr. Jiao”) was appointed as the chairman and a Non-Executive Director of our Company in August, 2018. He is responsible for participating in formulating the Group’s business and corporate strategies. Mr. Jiao joined our Group and served as a director of Taizhou Pharmaceutical since February 2015.

Independent non-executive Director

• Mr. Guo Liangzhong - Independent non-executive Director

  Mr. Guo Liangzhong (“Mr. Guo”) is an Independent Non-Executive Director of our Company and was appointed as a Director in August, 2018, effective from May 31, 2019. Mr. Guo worked as an officer in the accusation department at the Supreme People’s Procuratorate of the People’s Republic from March 1991 to July 1993.

• Dr. Zhang Yanyun - Independent non-executive Director

  Dr. Zhang Yanyun (“Dr. Zhang”) is an Independent Non-Executive Director of our Company and was appointed as a Director in August, 2018,effective from May 31, 2019. Dr. Zhang has been a non-resident research fellow and principal investigator at Shanghai Institute for Biological Sciences, Chinese Academy of Sciences since 2017.

• Mr. Leung, Louis Ho Ming - Independent non-executive Director

  Mr. Leung, Louis Ho Ming (“Mr. Leung") is an Independent Non-Executive Director of our Company and was appointed as a Director in June, 2022. Mr. Leung holds abachelor degree of Science in Quantitative Finance from The Chinese University of Hong Kong in 2004. He has been a member of Hong Kong Institute of Certified Public Accountant since 2008 and has over 10 years of experience in accounting and auditing for Hong Kong listed and private companies.